Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -8.13%5.66B | 3.92%11.94B | 13.80%6.17B | 6.27%11.49B | -2.19%5.42B | 1.57%10.81B | 5.01%5.54B | 38.61%10.65B | 63.12%5.28B | 1.30%7.68B |
| Operating income | -8.13%5.66B | 3.92%11.94B | 13.80%6.17B | 6.27%11.49B | -2.19%5.42B | 1.57%10.81B | 5.01%5.54B | 38.61%10.65B | 63.12%5.28B | 1.30%7.68B |
| Cost of sales | 8.35%-4.54B | -4.91%-9.75B | -12.89%-4.96B | -8.80%-9.29B | -0.25%-4.39B | 0.49%-8.54B | -4.20%-4.38B | -39.49%-8.58B | -60.92%-4.2B | -0.55%-6.15B |
| Operating expenses | 8.35%-4.54B | -4.91%-9.75B | -12.89%-4.96B | -8.80%-9.29B | -0.25%-4.39B | 0.49%-8.54B | -4.20%-4.38B | -39.49%-8.58B | -60.92%-4.2B | -0.55%-6.15B |
| Gross profit | -7.25%1.12B | -0.28%2.19B | 17.66%1.21B | -3.21%2.2B | -11.43%1.03B | 10.10%2.27B | 8.20%1.16B | 35.09%2.06B | 72.40%1.07B | 4.41%1.53B |
| Selling expenses | -0.30%-505.97M | -35.62%-1.08B | -37.25%-504.44M | 24.95%-796.35M | 31.10%-367.54M | -6.17%-1.06B | -33.00%-533.45M | -76.95%-999.34M | -95.89%-401.07M | -3.77%-564.74M |
| Administrative expenses | 6.87%-192.62M | 9.44%-413.83M | 7.57%-206.82M | -1.05%-456.97M | -4.41%-223.76M | 2.42%-452.23M | -4.80%-214.32M | 17.72%-463.45M | -27.35%-204.51M | -47.37%-563.28M |
| Research and development expenses | 5.28%-145.97M | -36.03%-232.23M | -68.98%-154.1M | -0.88%-170.72M | 1.31%-91.19M | -21.92%-169.23M | -63.65%-92.41M | -27.94%-138.8M | -3.44%-56.47M | -1.30%-108.49M |
| Impairment and provision | -81.14%-10.68M | 103.53%918K | -108.08%-5.9M | -922.22%-26M | -277.79%-2.83M | 66.12%-2.54M | 125.79%1.59M | -202.12%-7.51M | -3,053.06%-6.18M | 129.01%7.35M |
| -Other impairment is provision | -81.14%-10.68M | 103.53%918K | -108.08%-5.9M | -922.22%-26M | -277.79%-2.83M | 66.12%-2.54M | 125.79%1.59M | -202.12%-7.51M | -3,053.06%-6.18M | 129.01%7.35M |
| Special items of operating profit | 44.13%205.7M | 25.09%273.71M | 12.73%142.72M | -38.38%218.81M | 8.18%126.6M | 180.39%355.07M | 193.50%117.03M | 0.46%126.63M | -53.38%39.87M | -26.48%126.05M |
| Operating profit | -1.79%471.59M | -23.36%742.85M | 2.48%480.18M | 2.72%969.28M | 6.91%468.55M | 62.00%943.57M | -1.19%438.27M | 36.92%582.44M | 54.46%443.57M | -26.21%425.4M |
| Financing cost | -9.63%-113.41M | 5.49%-220.71M | 2.77%-103.44M | -17.39%-233.53M | -9.08%-106.39M | -21.72%-198.94M | -30.07%-97.54M | -101.87%-163.44M | -160.75%-74.99M | -98.88%-80.96M |
| Earning before tax | -4.93%358.18M | -29.03%522.14M | 4.03%376.74M | -1.19%735.75M | 6.29%362.16M | 77.72%744.64M | -7.56%340.73M | 21.65%419M | 42.63%368.58M | -35.71%344.44M |
| Tax | 19.77%-74.96M | -36.54%-134.3M | -40.17%-93.43M | 47.24%-98.36M | 18.94%-66.66M | -66.40%-186.43M | -18.53%-82.23M | 33.70%-112.04M | -11.80%-69.38M | -30.74%-168.99M |
| After-tax profit from continuing operations | -0.03%283.22M | -39.15%387.83M | -4.13%283.31M | 14.18%637.39M | 14.31%295.5M | 81.85%558.21M | -13.60%258.51M | 74.96%306.97M | 52.37%299.21M | -56.84%175.45M |
| Earning after tax | -0.03%283.22M | -39.15%387.83M | -4.13%283.31M | 14.18%637.39M | 14.31%295.5M | 81.85%558.21M | -13.60%258.51M | 74.96%306.97M | 52.37%299.21M | -56.84%175.45M |
| Minority profit | -7.52%84.3M | -36.81%118.79M | -11.90%91.15M | -10.41%187.99M | 10.38%103.46M | 138.14%209.82M | 10.07%93.73M | 45.75%88.11M | 38.43%85.16M | -49.93%60.45M |
| Profit attributable to shareholders | 3.52%198.92M | -40.13%269.05M | 0.06%192.16M | 28.99%449.4M | 16.55%192.04M | 59.19%348.39M | -23.02%164.78M | 90.32%218.86M | 58.73%214.05M | -59.76%115M |
| Basic earnings per share | 0.58%0.1037 | -47.43%0.1423 | -10.89%0.1031 | 28.97%0.2707 | 16.52%0.1157 | 55.94%0.2099 | -25.73%0.0993 | 82.14%0.1346 | 50.90%0.1337 | -60.88%0.0739 |
| Diluted earnings per share | 0.59%0.103 | -47.42%0.1414 | -10.80%0.1024 | 28.78%0.2689 | 16.19%0.1148 | 56.17%0.2088 | -25.71%0.0988 | 81.90%0.1337 | 50.96%0.133 | -60.88%0.0735 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Touche Tohmatsu CPA LLP | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Touche Tohmatsu CPA LLP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.